Quantcast
Last updated on April 17, 2014 at 9:10 EDT

Latest HIV Stories

2014-04-01 16:25:28

Elizabeth Glaser Pediatric AIDS Foundation Applauds Agreement between the Medicines Patent Pool and ViiV Healthcare WASHINGTON, April 1, 2014 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) applauds the licensing agreement between the Medicines Patent Pool (MPP) and ViiV Healthcare to increase access to dolutegravir (DTG), a promising new antiretroviral (ARV) medication. This agreement will allow generic manufacturers to scale up production of...

2014-04-01 16:25:22

GENEVA, April 1, 2014 /PRNewswire/ -- Access to dolutegravir could improve millions of lives in developing countries The Medicines Patent Pool (MPP) and ViiV Healthcare announced a new collaboration on HIV medicines today, signing two licensing agreements to increase access to dolutegravir (DTG), a promising new antiretroviral, for both adult and paediatric care. The agreements would allow generic...

2014-04-01 16:25:15

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world LONDON, April 1, 2014 /PRNewswire/ -- ViiV Healthcare today announced new collaborations with the goal of increasing access to its HIV medicine, dolutegravir (marketed under the name Tivicay®), just two months after its approval by the European Medicines Agency (EMA) and eight months after approval by the US Food and Drug...

2014-04-01 14:04:36

Pressure from counselors and perceived ineffectiveness & irrelevance of intervention keep young adults from returning to follow-up sessions Keeping young people in human immunodeficiency virus (HIV) prevention programs is a major goal in reducing the incidence of HIV, and multi-session interventions are often more effective than single-sessions. But according to a new study from the Annenberg School for Communication, the way these programs are designed and implemented may turn off the...

2014-04-01 12:56:08

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine. The finding is important, investigators say, because advances in treatment have led to long-term survival of people living with HIV/AIDS and the...

2014-04-01 08:28:25

RARITAN, N.J., April 1, 2014 /PRNewswire/ -- Janssen Research & Development, LLC (Janssen), today announced it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for a once-daily fixed-dose antiretroviral combination tablet containing darunavir, a protease inhibitor developed by Janssen R&D Ireland and marketed as PREZISTA(®) in the U.S., with cobicistat, an investigational pharmacokinetic enhancer or boosting agent, developed...

2014-04-01 08:26:47

National "GYT: Get Yourself Tested" Campaign Successfully Reaching Youth to Increase STD Awareness and Testing, According to New Study NEW YORK, April 1, 2014 /PRNewswire-USNewswire/ -- The sixth annual national GYT: Get Yourself Tested campaign will kick off on Tuesday, April 1, in honor of National STD Awareness Month, with on-air, online, and on-the-ground activities across the country. GYT is designed to promote sexual health and address the disproportionately high rates of sexually...

2014-03-31 20:21:42

DUBLIN, April 1, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/hnfpj3/hiv_vaccine) has announced the addition of the "HIV Vaccine Market Opportunity & Clinical Pipeline Analysis" [http://www.researchandmarkets.com/research/hnfpj3/hiv_vaccine ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Ever since HIV was identified as the cause for AIDS 30 years ago, the HIV virus has become...

2014-03-31 09:41:18

Researchers at the University of Texas Medical Branch at Galveston by growing vaginal skin cells outside the body and studying the way they interact with "good and bad" bacteria, think they may be able to better identify the good bacteria that protect women from HIV infection and other sexually transmitted infections. The health of the human vagina depends on a symbiotic/mutually beneficial relationship with "good" bacteria that live on its surface feeding on products produced by vaginal...

2014-03-29 23:01:50

YourLifeSolution.com has just released their assessment of life insurance for HIV positive people. Chicago, IL (PRWEB) March 29, 2014 YourLifeSolution.com is a service which displays life insurance quotes to users without requiring personal information. The service is today releasing their assessment on life insurance for HIV positive people. Their analysis finds that while it is possible for someone with HIV to purchase life insurance, the caveats generally outweigh the benefit of...


Latest HIV Reference Libraries

Sooty Mangabey, Cercocebus atys
2012-06-28 20:49:18

The sooty mangabey (Cercocebus atys) is an Old World Monkey that can be found throughout the area stretching from Senegal to eastern Ghana. Its other common names include the white-naped mangabey, the white-crowned mangabey, and the white-collared mangabey, which causes some confusion with the collared mangabey. There are currently two recognized subspecies of this mangabey, although they can be considered distinct species. The sooty mangabey resides in forests within its range, preferring...

70_dd0fb65b7366091c1e0897e58f1798fa
2011-02-23 20:58:48

Simian immunodeficiency virus (SIV), also known as African Green Monkey virus, is a retrovirus able to infect at least 33 species of African primates. SIV has been present in monkeys and apes for at least 32,000 years, probably longer. Strains from two of these primate species have crossed the barriers into humans resulting in HIV-2 and HIV-1. Contraction involves contact with the blood of chimps that are often hunted for bushmeat in Africa. SIV infections appear in many cases to be...

0_a4499f7c8759b5cbe79bad5eca319070
2011-01-26 14:08:59

Human immunodeficiency virus (HIV), a lentivirus, causes acquired immunodeficiency syndrome (AIDS) which is a condition in humans were the immune system begins to fail, leading to life-threatening opportunistic infections. Infection is transferred through bodily fluids where HIV is present as both free virus particles and within infected immune cells. The four most common routes of infection are unsafe sex, contaminated needles, breast milk, and transmission from an infected mother to her...

69_d42a67c9e67a58fec0ffaab2b08808b2
2011-01-12 16:27:29

The common cold is a viral disease of the upper respiratory system, caused primarily by rhinoviruses and coronaviruses. Symptoms usually include a cough, sore throat, runny nose, and a fever. There is no known treatment to shorten the duration of the virus yet the cold normally dissipates after 7 to 10 days. It is the most common infectious disease in humans who on average are infected two to four times a year in adults. It can also be called a upper respiratory tract infection. Other...

45_10ad4db95d2f95cace360b9700900049
2011-01-05 13:01:59

The African Swine Fever virus, ASFV, is a double-stranded DNA virus that replicates in the cytoplasm of infected cells. It can affect most pigs, wild and domesticated, as well as soft ticks. It is the only virus with a DNA genome that is transmitted by arthropods. The virus causes a lethal hemorrhagic disease in domestic pigs which sometimes leads to death in as little as a week. In every other species the virus causes no discernible disease. The virus is endemic to Sub-Saharan Africa...

More Articles (5 articles) »